Distribution and pharmacological characterization of primate NK-2 tachykinin receptor in the central nervous system of the rhesus monkey

Neuroscience Letters

Volumn 503, Issue 1, 2011, Pages 23-26

  Nagano, Masatoshi ^a   Oishi, Takao ^b   Suzuki, Hidenori ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Central nervous system; Neurokinin a; NK 1; NK 2; Primate; Tachykinin

Indexed keywords

NEUROKININ 2 RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CINGULATE GYRUS; MACACA MULATTA; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING;

ANIMALS; CENTRAL NERVOUS SYSTEM; CHO CELLS; CRICETINAE; HUMANS; MACACA MULATTA; MALE; NEUROKININ A; NEUROKININ B; PROTEIN BINDING; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; RNA, MESSENGER; SUBSTANCE P; TRANSFECTION;

EID: 80052650175     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.07.057     Document Type: Article

References (37)

1. Aharony D., Little J., Powell S., Hopkins B., Bundell K.R., McPheat W.L., Gordon A.D., Hassall G., Hockney A., Griffin R., Graham A. Pharmacological characterization of cloned human NK-2 (neurokinin A) receptor expressed in a baculovirus/Sf-21 insect cell system. Mol. Pharmacol. 1993, 44:356-363.
2. Aramori I., Morikawa N., Zenkoh J., O'Donnell N., Iwami M., Kojo H., Notsu Y., Okuhara M., Ono S., Nakanishi S. Subtype- and species-selectivity of a tachykinin receptor antagonist, FK888, for cloned rat and human tachykinin receptors. Eur. J. Pharmacol. 1994, 269:277-281.
3. Beaujouan J.C., Saffroy M., Torrens Y., Glowinski J. Different subtypes of tachykinin NK1 receptor binding sites are present in the rat brain. J. Neurochem. 2000, 75:1015-1026.
4. Bensaid M., Faucheux B.A., Hirsch E., Agid Y., Soubrié P., Oury-Donat F. Expression of tachykinin NK2 receptor mRNA in human brain. Neurosci. Lett. 2001, 303:25-28.
5. Canteras N.S., Resstel L.B., Bertoglio L.J., Carobrez A.P., Guimarães F.S. Neuroanatomy of anxiety. Curr. Top. Behav. Neurosci. 2010, 2:77-96.
6. Cronenwett W.J., Csernansky J. Thalamic pathology in schizophrenia. Curr. Top. Behav. Neurosci. 2010, 4:509-528.
7. Dietl M.M., Palacios J.M. Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain. Brain Res. 1991, 539:211-222.
8. Ebner K., Sartori S.B., Singewald N. Tachykinin receptors as therapeutic targets in stress-related disorders. Curr. Pharm. Des. 2009, 15:1647-1674.
9. Graham A., Hopkins B., Powell S., Danks P., Briggs I. Isolation and characterisation of the human lung NK-2 receptor gene using rapid amplification of cDNA ends. Biochem. Biophys. Res. Commun. 1991, 177:8-16.
10. Hayashi M., Oshima K. Neuropeptides in cerebral cortex of Macaque monkey (Macaca fuscata fuscata): regional distribution and ontogeny. Brain Res. 1986, 364:360-368.
11. Hurd Y.L., Keller E., Sotonyi P., Sedvall G. Preprotachykinin-A mRNA expression in the human and monkey brain: an in situ hybridization study. J. Comp. Neurol. 1999, 411:56-72.
12. Husum H., Vasquez P.A.J., Mathé A.A. Changed concentrations of tachykinins and neuropeptide Y in brain of a rat model of depression: lithium treatment normalizes tachykinins. Neuropsychopharmacology 2001, 24:183-191.
13. Hutsler J.J., Chalupa L.M., Substance P immunoreactivity identifies a projection from the cat's superior colliculus to the principal tectorecipient zone of the lateral posterior nucleus. J. Comp. Neurol. 1991, 312:379-390.
14. Lechner J., Leah J.D., Zimmermann M. Brainstem peptidergic neurons projecting to the medial and lateral thalamus and zona incerta in the rat. Brain Res. 1993, 603:47-56.
15. Maggi C.A. The mammalian tachykinin receptors. Gen. Pharmacol. 1995, 26:911-944.
16. Mantyh P.W., Hunt S.P. The autoradiographic localization of substance P receptors in the rat and bovine spinal cord and the rat and cat spinal trigeminal nucleus pars caudalis and the effects of neonatal capsaicin. Brain Res. 1985, 332:315-324.
17. Masterson S.P., Li J., Bickford M.E. Frequency-dependent release of substance P mediates heterosynaptic potentiation of glutamatergic synaptic responses in the rat visual thalamus. J. Neurophysiol. 2010, 104:1758-1767.
18. Mehler-Wex C., Riederer P., Gerlach M. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox. Res. 2006, 10:167-179.
19. Micale V., Tamburella A., Leggio G.M., Mazzola C., Li Volsi V., Drago F. Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions. Pharmacol. Biochem. Behav. 2008, 90:463-469.
20. Nagano M., Saitow F., Haneda E., Konishi S., Hayashi M., Suzuki H. Distribution and pharmacological characterization of primate NK-1 and NK-3 tachykinin receptors in the central nervous system of the rhesus monkey. Br. J. Pharmacol. 2006, 147:316-323.
21. Nakanishi S. Mammalian tachykinin receptors. Annu. Rev. Neurosci. 1991, 14:123-136.
22. Oishi T., Higo N., Umino Y., Matsuda K., Hayashi M. Development of GAP-43 mRNA in the macaque cerebral cortex. Dev. Brain Res. 1998, 109:87-97.
23. Otsuka M., Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 1993, 73:229-308.
24. Overstreet D.H., Naimoli V.M., Griebel G. Saredutant, an NK2 receptor antagonist, has both antidepressant-like effects and synergizes with desipramine in an animal model of depression. Pharmacol. Biochem. Behav. 2010, 96:206-210.
25. Pinto F.M., Almeida T.A., Hernandez M., Devillier P., Advenier C., Candenas M.L. mRNA expression of tachykinins and tachykinin receptors in different human tissues. Eur. J. Pharmacol. 2004, 494:233-239.
26. Quartara L., Altamura M. Tachykinin receptors antagonists: from research to clinic. Curr. Drug Targets 2006, 7:975-992.
27. Rigby M., O'Donnell R., Rupniak N.M.J. Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain. J. Comp. Neurol. 2005, 490:335-353.
28. Saffroy M., Torrens Y., Glowinski J., Beaujouan J.C. Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites. Neuroscience 2003, 116:761-773.
29. Sagan S., Beaujouan J.C., Torrens Y., Saffroy M., Chassaing G., Glowinski J., Lavielle S. High affinity binding of [3H]propionyl-[Met(O2)11] substance P(7-11), a tritiated septide-like peptide, in Chinese hamster ovary cells expressing human neurokinin-1 receptors and in rat submandibular glands. Mol. Pharmacol. 1997, 52:120-127.
30. Sharpley C.F. A review of the neurobiological effects of psychotherapy for depression. Psychotherapy 2010, 47:603-615.
31. Stepniewska I I., Ql H.X., Kaas J.H. Projections of the superior colliculus to subdivisions of the inferior pulvinar in new world and old world monkeys. Vis. Neurosci. 2000, 17:529-549.
32. Suzuki H., Yoshioka K., Maehara T., Hagan R.M., Nakanishi S., Otsuka M. Pharmacological characteristics of tachykinin receptors mediating acetylcholine release from neonatal rat spinal cord. Eur. J. Pharmacol. 1993, 241:105-110.
33. Teixeira R.M., Santos A.R.S., Ribeiro S.J., Calixto J.B., Rae G.A., De Lima T.C.M. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. Eur. J. Pharmacol. 1996, 311:7-14.
34. Tooney P.A., Au G.G., Chahl L.A. Tachykinin NK1 and NK3 receptors in the prefrontal cortex of the human brain. Clin. Exp. Pharmacol. Physiol. 2000, 27:947-949.
35. Tracy I., Mantyh P.W. The cerebral signature for pain perception and its modulation. Neuron 2007, 55:377-391.
36. von Bonin G., Bailey P. The Neocortex of Macaca mulatta 1947, The University of Illinois Press, Urbana, IL.
37. Whitty C.J., Paul M.A., Bannon M.J. Neurokinin receptor mRNA localization in human midbrain dopamine neurons. J. Comp. Neurol. 1997, 382:394-400.